{"id":"W4389446815","doi":"10.1212/wnl.96.15_supplement.1847","title":"Randomized, Double-blind Controlled Trial Assessing The Dose Response And Safety Of Deflazacort In Boys With Duchenne Muscular Dystrophy (1847)","year":2021,"lang":"en","type":"article","venue":"Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Deflazacort; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Double blind; Physical therapy; Internal medicine; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001629701,0.00123577,0.003850025,0.0005250451,0.0005415835,0.0008422029,0.001010876,0.002525771,0.009556375],"category_scores_gemma":[0.002835802,0.000707129,0.001327496,0.0004493156,0.001274237,0.0008372711,0.0003465335,0.002662745,0.001223994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007442793,"about_ca_system_score_gemma":0.001296571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001973585,"about_ca_topic_score_gemma":0.003316071,"domain_scores_codex":[0.9991917,0.0004727622,0.00005973003,0.0001212708,0.00005509846,0.00009947229],"domain_scores_gemma":[0.9981986,0.0007405791,0.0003381691,0.0001330645,0.000144921,0.0004447458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9901618,0.002521631,0.0001498197,0.0004585192,0.0004205274,0.00002244,0.00001837511,0.0000825322,0.001148203,0.00006980223,0.000430331,0.004515951],"study_design_scores_gemma":[0.9775612,0.0213484,0.0004485086,0.00001589037,0.0001334037,0.00001048895,0.000007600132,0.00009838215,0.0001318984,0.00003621825,0.0002026042,0.000005346708],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680015,0.01015318,0.001470338,0.001095531,0.002045994,0.01064736,0.002384577,0.0003634901,0.003838194],"genre_scores_gemma":[0.9718759,0.0042143,0.003289596,0.001681343,0.000883378,0.01030671,0.001433875,0.0000418111,0.006273079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009556375,"threshold_uncertainty_score":0.03196931,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0127269855972051,"score_gpt":0.2752360061374014,"score_spread":0.2625090205401963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}